Anouk M. Wijnands,Bas B.L. Penning de Vries,Maurice W.M.D. Lutgens,Zeinab Bakhshi,Ibrahim Al Bakir,Laurent Beaugerie,Charles N. Bernstein,Ryan Chang-ho Choi,Nayantara Coelho-Prabhu,Trevor A. Graham,Ailsa L. Hart,Joren R. ten Hove,Steven H. Itzkowitz,Julien Kirchgesner,Erik Mooiweer,Seth R. Shaffer,Shailja C. Shah,Sjoerd G. Elias,Bas Oldenburg,Dutch Initiative on Crohn and Colitis,Adriaan A. van Bodegraven,Herma H. Fidder,Meike M.C. Hirdes,Frank Hoentjen,Jeroen M. Jansen,Nofel Mahmmod,Andrea E. van der Meulen-de Jong,Cyriel Y. Ponsioen,Fiona D.M. van Schaik,C. Janneke van der Woude

Abstract:BACKGROUND & AIMS: <AbstractText Label="BACKGROUND &amp; AIMS" NlmCategory="OBJECTIVE">Colonoscopic surveillance is recommended in patients with colonic inflammatory bowel disease (IBD) given their increased risk of colorectal cancer (CRC). We aimed to develop and validate a dynamic prediction model for the occurrence of advanced colorectal neoplasia (aCRN, including high-grade dysplasia and CRC) in IBD.</AbstractText>METHODS: <AbstractText Label="METHODS" NlmCategory="METHODS">We pooled data from six existing cohort studies from Canada, the Netherlands, the UK, and the USA. Patients with IBD and an indication for CRC surveillance were included if they underwent at least one follow-up procedure. Exclusion criteria included prior aCRN, prior colectomy, or an unclear indication for surveillance. Predictor variables were selected based on literature. A dynamic prediction model was developed using a landmarking approach based on Cox proportional hazard modelling. Model performance was assessed with Harrell's concordance-statistic (discrimination) and by calibration curves. Generalizability across surveillance cohorts was evaluated by internal-external cross-validation.</AbstractText>RESULTS: <AbstractText Label="RESULTS" NlmCategory="RESULTS">The surveillance cohorts comprised 3,731 patients, enrolled and followed-up in the time period 1973-2021, with a median follow-up of 5.7 years (26,336 patient-years of follow-up); 146 individuals were diagnosed with aCRN. The model contained eight predictors, with a cross-validation median c-statistic of 0.74 and 0.75 for a 5- and 10-year prediction window, respectively. Calibration plots showed good calibration. Internal-external cross-validation results showed medium discrimination and reasonable to good calibration.</AbstractText>CONCLUSION: <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The new prediction model showed good discrimination and calibration, however, generalizability results varied. Future research should focus on formal external validation and relate predicted aCRN risks to surveillance intervals prior to clinical application.</AbstractText>

S1406 The Natural History of Dysplasia in Inflammatory Bowel Disease: Results of a Markov Model

Optimising inflammatory bowel disease surveillance and dysplasia management-Where do we stand?

A Systematic Review and Meta-Analysis of Endoscopic Surveillance Studies for Detecting Dysplasia in Patients With Inflammatory Bowel Disease

Measuring the concordance between endoscopic and histologic inflammation and its effect on IBD-associated dysplasia

From random to precise: updated colon cancer screening and surveillance for inflammatory bowel disease

Endoscopic approaches to the management of dysplasia in inflammatory bowel disease: A state-of-the-art narrative review

An Updated Approach to Dysplasia in IBD

Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?

Dynamic prediction of advanced colorectal neoplasia in inflammatory bowel disease

Reappraising Risk Factors for Inflammatory Bowel Disease-associated Neoplasia: Implications for Colonoscopic Surveillance in IBD

Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management

Causal Linkage Between Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Two-Sample Mendelian Randomization Analysis

An Update on Surveillance in Ulcerative Colitis

Practice pattern variability among gastroenterologists in colorectal cancer surveillance and management of colorectal dysplasia in inflammatory bowel disease

Gut Microbial Impact on Colitis and Colitis-Associated Carcinogenesis in a Primary Sclerosing Cholangitis-IBD Model

Perception of Cancer Risk and Management Practice for Colitis-associated Dysplasia Is Influenced by Colonoscopy Experience and Workplace Affiliation: Results of an International Clinician Survey

Inflammatory bowel disease-related colorectal cancer: Past, present and future perspectives

Machine Learning Prediction Model for Inflammatory Bowel Disease Based on Laboratory Markers. Working Model in a Discovery Cohort Study

Colorectal cancer in inflammatory bowel disease: review of the evidence

What Is the Risk? Epidemiology and Evidence for Surveillance Regimens

Ulcerative colitis and colon cancer: Biology and surveillance